BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36628358)

  • 1. Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry.
    Favre G; Maisonneuve E; Pomar L; Daire C; Poncelet C; Quibel T; Monod C; Martinez de Tejada B; Schäffer L; Papadia A; Radan AP; Todesco-Bernasconi M; Ville Y; Voekt CA; Eggel-Hort B; Capoccia-Brugger R; Johann S; Grawe C; Defert S; Mottet N; Kahlert CR; Garabedian C; Sentilhes L; Weber B; Leu S; Bassler D; Lepigeon K; Winterfeld U; Panchaud A; Baud D;
    Lancet Reg Health Eur; 2023 Mar; 26():100569. PubMed ID: 36628358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
    Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
    Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study.
    Stock SJ; Moore E; Calvert C; Carruthers J; Denny C; Donaghy J; Hillman S; Hopcroft LEM; Hopkins L; Goulding A; Lindsay L; McLaughlin T; Taylor B; Auyeung B; Katikireddi SV; McCowan C; Ritchie LD; Rudan I; Simpson CR; Robertson C; Sheikh A; Wood R
    Lancet Respir Med; 2022 Dec; 10(12):1129-1136. PubMed ID: 36216011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Infection with Different SARS-CoV-2 Variants during Pregnancy with Maternal and Perinatal Outcomes: A Systematic Review and Meta-Analysis.
    Deng J; Ma Y; Liu Q; Du M; Liu M; Liu J
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and infant outcomes following SARS-CoV-2 infection in pregnancy during delta variant predominance - Surveillance for Emerging Threats to Pregnant People and Infants.
    Reeves EL; Neelam V; Carlson JM; Olsen EO; Fox CJ; Woodworth KR; Nestoridi E; Mobley E; Montero Castro S; Dzimira P; Sokale A; Sizemore L; Hall AJ; Ellington S; Cohn A; Gilboa SM; Tong VT
    Am J Obstet Gynecol MFM; 2024 Feb; 6(2):101265. PubMed ID: 38135220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-Delta, Delta, and Omicron Periods of the Coronavirus Disease 2019 (COVID-19) Pandemic and Health Outcomes During Delivery Hospitalization.
    Carlson J; Simeone RM; Ellington S; Galang R; DeSisto CL; Fleming-Dutra K; Riley L; Meaney-Delman D; Tong VT
    Obstet Gynecol; 2024 Jan; 143(1):131-138. PubMed ID: 37917932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of SARS-CoV-2 infection in pregnant women and their neonates during the Omicron period compared to the pre-Omicron period: A retrospective cohort study.
    Yamaguchi T; Makino Y; Mabuchi Y; Okuda K; Hayashi H; Kato N; Fujii T; Hirate H
    J Obstet Gynaecol Res; 2023 May; 49(5):1348-1354. PubMed ID: 36781158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of maternal infection and perinatal outcomes during periods of SARS-CoV-2 wildtype, alpha, and delta variant dominance in the UK: prospective cohort study.
    Vousden N; Ramakrishnan R; Bunch K; Morris E; Simpson NAB; Gale C; O'Brien P; Quigley M; Brocklehurst P; Kurinczuk JJ; Knight M
    BMJ Med; 2022; 1(1):e000053. PubMed ID: 36936566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Severe Maternal Morbidities Associated With Delivery During Periods of Circulation of Specific SARS-CoV-2 Variants.
    Mupanomunda M; Fakih MG; Miller C; Ottenbacher A; Winegar AL; Roberts P; Kimathi M; Gianopoulos JG; Cahill AG; Cacchione JG; Fogel RI; Aloia TA; Masoudi FA
    JAMA Netw Open; 2022 Aug; 5(8):e2226436. PubMed ID: 35960519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study.
    Charles CM; Osman NB; Arijama D; Matingane B; Sitoé T; Kenga D; Lorenzoni C; Luís E; Pacagnella RC; Sacarlal J;
    Reprod Health; 2022 Jul; 19(1):164. PubMed ID: 35854384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.
    Villar J; Soto Conti CP; Gunier RB; Ariff S; Craik R; Cavoretto PI; Rauch S; Gandino S; Nieto R; Winsey A; Menis C; Rodriguez GB; Savasi V; Tug N; Deantoni S; Fabre M; Martinez de Tejada B; Rodriguez-Sibaja MJ; Livio S; Napolitano R; Maiz N; Sobrero H; Peterson A; Deruelle P; Giudice C; Teji JS; Casale RA; Salomon LJ; Prefumo F; Cheikh Ismail L; Gravett MG; Vale M; Hernández V; Sentilhes L; Easter SR; Capelli C; Marler E; Cáceres DM; Albornoz Crespo G; Ernawati E; Lipschuetz M; Takahashi K; Vecchiarelli C; Hubka T; Ikenoue S; Tavchioska G; Bako B; Ayede AI; Eskenazi B; Thornton JG; Bhutta ZA; Kennedy SH; Papageorghiou AT;
    Lancet; 2023 Feb; 401(10375):447-457. PubMed ID: 36669520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods.
    Shoji K; Tsuzuki S; Akiyama T; Matsunaga N; Asai Y; Suzuki S; Iwamoto N; Funaki T; Yamada M; Ozawa N; Yamaguchi K; Miyairi I; Ohmagari N
    J Infect Chemother; 2023 Jan; 29(1):33-38. PubMed ID: 36103949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
    Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
    J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study.
    Sankar K; Modi N; Polyak A; Directo MP; Johnson LR; Kho N; Isonaka SK; Pedraza I; Chen P; Modes ME
    BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36805880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study.
    Donati S; Corsi E; Maraschini A; Salvatore MA;
    BJOG; 2022 Jan; 129(2):221-231. PubMed ID: 34687585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal vaccination against COVID-19 and neonatal outcomes during Omicron: INTERCOVID-2022 study.
    Barros FC; Gunier RB; Rego A; Sentilhes L; Rauch S; Gandino S; Teji JS; Thornton JG; Kachikis AB; Nieto R; Craik R; Cavoretto PI; Winsey A; Roggero P; Rodriguez GB; Savasi V; Kalafat E; Giuliani F; Fabre M; Benski AC; Coronado-Zarco IA; Livio S; Ostrovska A; Maiz N; Castedo Camacho FR; Peterson A; Deruelle P; Giudice C; Casale RA; Salomon LJ; Soto Conti CP; Prefumo F; Mohamed Elbayoumy EZ; Vale M; Hernández V; Chandler K; Risso M; Marler E; Cáceres DM; Crespo GA; Ernawati E; Lipschuetz M; Ariff S; Takahashi K; Vecchiarelli C; Hubka T; Ikenoue S; Tavchioska G; Bako B; Ayede AI; Eskenazi B; Bhutta ZA; Kennedy SH; Papageorghiou AT; Villar J;
    Am J Obstet Gynecol; 2024 Feb; ():. PubMed ID: 38367758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study.
    Favre G; Maisonneuve E; Pomar L; Winterfeld U; Daire C; Martinez de Tejada B; Delecraz D; Campelo S; Moser M; Todesco-Bernasconi M; Sturm S; Hösli I; Monod C; Frey Tirri B; Kalimeris S; Blume C; Mathis J; Zimmerman R; Radan AP; Surbek D; Baud D; Panchaud A
    Lancet Reg Health Eur; 2022 Jul; 18():100410. PubMed ID: 35651954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.